Top U.S. proton pump inhibitors market share based on prescriptions 2013
This statistic displays the market share of the top ten proton pump inhibitors based on total U.S. prescriptions in 2013. In that year, Nexium was among the leading proton pump inhibitors with a total market share of 15.4 percent of prescriptions in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.
